2001至2023年德国报告肠道热流行病学特征与趋势
分析德国2001至2023年符合病例定义的肠道热通报,共2670例确诊病例,其中56%为伤寒沙门菌、44%为副伤寒沙门菌。多数病例为境外输入,住院率高且抗菌药物耐药常见,伤寒疫苗接种率低。
要点
- 2001至2023年共通报2670例肠道热确诊病例,伤寒沙门菌占56%,副伤寒沙门菌占44%。
- 86%的病例为境外获得,最常见暴露国家为印度、巴基斯坦和土耳其。
- 住院率总体78%,伤寒沙门菌组85%高于副伤寒沙门菌组70%(p < 0.001)。
核心结论
- 大多数肠道热病例为境外输入,住院率高且抗菌药物耐药常见。
- 伤寒疫苗接种利用不足,作者强调需要更多途径向高危旅行者提供信息和疫苗接种服务。
研究设计与样本
- 分析德国2001至2023年符合病例定义的肠道热通报数据。
- 计算2012至2023年按暴露国家划分的每10万名航空旅客中输入性肠道热病例数。
主要发现
- 2001至2023年共通报2670例确诊病例:伤寒沙门菌56%(1498/2670),副伤寒沙门菌44%(1172/2670),季节性高峰在4至5月和8至9月。
- 除COVID-19相关旅行限制年份外,伤寒沙门菌通报稳定,而副伤寒沙门菌通报下降。
- 病例中位年龄26岁(范围0至93岁),男性占55%(1458/2663)。
- 有信息的病例中,93%(2491/2670)有发热,71%(1906/2670)有腹泻,78%(2033/2607)住院(伤寒沙门菌85%(1234/1459) vs 副伤寒沙门菌70%(799/1148),p < 0.001),4例死亡(伤寒沙门菌2例、副伤寒沙门菌A 1例、副伤寒沙门菌B 1例)。
- 伤寒沙门菌病例中7%(88/1221)报告接种过疫苗;86%(2251/2613)的病例为境外获得,最常见于印度、巴基斯坦和土耳其。
关键数值与推荐
- 2017年以来有信息的病例中,环丙沙星耐药报告于50/59例伤寒沙门菌和16/18例副伤寒沙门菌A病例。
- 头孢噻肟耐药报告于10/57例伤寒沙门菌病例,暴露地为巴基斯坦(9/10)和印度(1/10)。
临床怎么用
- 作者认为伤寒疫苗接种利用不足,强调需要额外途径向高危旅行者提供信息和疫苗接种服务。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundEnteric fevers (EF) are caused by infections with Salmonella Typhi (STY) or Salmonella Paratyphi (SP) A-C (except the SPB enteric pathovar) and exhibit increasing antimicrobial resistance (AMR). Notification is mandatory in Germany.AimTo describe characteristics and trends of notified EF cases in Germany.MethodsWe analysed German EF notifications 2001-2023 fulfilling the case definition. We calculated numbers of imported EF cases per 100,000 air travellers by country of exposure 2012-2023.ResultsIn 2001-2023, 2,670 confirmed EF cases were notified: 56% (1,498/2,670) STY, 44% (1,172/2,670) SP, with seasonal peaks in April-May and August-September. Aside from years with COVID-19-related travel restrictions, STY notifications were stable, while SP notifications decreased. Median age of EF cases was 26 years (range: 0-93) and 55% (1,458/2,663) were male. Of cases with information, 93% (2,491/2,670) had fever, 71% (1,906/2,670) diarrhoea, 78% (2,033/2,607) were hospitalised (STY: 85% (1,234/1,459) vs SP: 70% (799/1,148), p < 0.001) and four died (two STY, one SPA, one SPB). Of STY cases, 7% (88/1,221) reported vaccination. Overall, 86% (2,251/2,613) of cases acquired EF abroad, most commonly in India, Pakistan and Türkiye. Ciprofloxacin resistance was reported for 50/59 STY and 16/18 SPA cases and cefotaxime resistance for 10/57 STY cases (exposure: Pakistan (9/10), India (1/10)) with information since 2017. We also report outbreaks and incidence among travellers.ConclusionsMost cases were imported and had high hospitalisation rates and AMR. Typhoid vaccination was underutilised, highlighting that additional ways to reach at-risk travellers with information and vaccination offers are needed.
引用
- Enkelmann J, Simon S, Trost E, et al. Epidemiological characteristics and trends of notified enteric fevers in Germany, 2001 to 2023. Euro Surveill. 2025. PMID: 40211970. doi:10.2807/1560-7917.ES.2025.30.14.2400314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。